Tempest Therapeutics, Inc. (TPST) stock
TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38−0.00 (-0.29%)
Close on Nov 13, 2026Market cap $5.65MP/E –Yield –
Tempest Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Tempest Therapeutics's total debt was $0 at Dec 31, 2025. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $15.07M in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | -100.0% |
| FY2024 | Dec 31, 2024 | $6.35M | -39.8% |
| FY2023 | Dec 31, 2023 | $10.55M | +1.7% |
| FY2022 | Dec 31, 2022 | $10.37M | -31.2% |
| FY2021 | Dec 31, 2021 | $15.07M | +6205.0% |
| FY2020 | Dec 31, 2020 | $239.00K | -36.4% |
| FY2019 | Dec 31, 2019 | $376.00K | -34.3% |
| FY2018 | Dec 31, 2018 | $572.00K | -26.0% |
| FY2017 | Dec 31, 2017 | $773.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $4.19M | -60.5% |
| Q4 FY2024 | Dec 31, 2024 | $6.35M | -39.8% |
| Q3 FY2024 | Sep 30, 2024 | $8.50M | -19.0% |
| Q2 FY2024 | Jun 30, 2024 | $10.65M | +1.9% |
| Q1 FY2024 | Mar 31, 2024 | $10.60M | +1.7% |
| Q4 FY2023 | Dec 31, 2023 | $10.55M | +1.7% |
| Q3 FY2023 | Sep 30, 2023 | $10.51M | -11.2% |
| Q2 FY2023 | Jun 30, 2023 | $10.46M | -21.4% |
| Q1 FY2023 | Mar 31, 2023 | $10.42M | -31.2% |
| Q4 FY2022 | Dec 31, 2022 | $10.37M | -31.2% |
| Q3 FY2022 | Sep 30, 2022 | $11.84M | -21.1% |
| Q2 FY2022 | Jun 30, 2022 | $13.30M | -10.8% |
| Q1 FY2022 | Mar 31, 2022 | $15.13M | -1.1% |
| Q4 FY2021 | Dec 31, 2021 | $15.07M | +6205.0% |
| Q3 FY2021 | Sep 30, 2021 | $15.01M | +6659.0% |
| Q2 FY2021 | Jun 30, 2021 | $14.92M | +3877.3% |
| Q1 FY2021 | Mar 31, 2021 | $15.30M | +4058.7% |
| Q4 FY2020 | Dec 31, 2020 | $239.00K | -36.4% |
| Q3 FY2020 | Sep 30, 2020 | $222.00K | -46.5% |
| Q2 FY2020 | Jun 30, 2020 | $375.00K | -21.4% |
| Q1 FY2020 | Mar 31, 2020 | $368.00K | -28.7% |
| Q4 FY2019 | Dec 31, 2019 | $376.00K | -34.3% |
| Q3 FY2019 | Sep 30, 2019 | $415.00K | -46.3% |
| Q2 FY2019 | Jun 30, 2019 | $477.00K | – |
| Q1 FY2019 | Mar 31, 2019 | $516.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $572.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $773.00K | – |
See a number that looks wrong?